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Abstract
The HIV-1 epidemic in West Africa has been dominated by subtype A and the recombinant form CRF02_AG. Little is known
about the origins and the evolutionary history of HIV-1 in this region. We employed Maximum likelihood and Bayesian
methods in combination with temporal and spatial information to reconstruct the HIV-1 subtype distribution, demographic
history and migration patterns over time in Guinea-Bissau, West Africa. We found that CRF02_AG and subsubtype A3 were
the dominant forms of HIV-1 in Guinea-Bissau and that they were introduced into the country on at least six different
occasions between 1976 and 1981. These estimates also corresponded well with the first reported HIV-1 cases in Guinea-
Bissau. Migration analyses suggested that (1) the HIV-1 epidemic started in the capital Bissau and then dispersed into more
rural areas, and (2) the epidemic in Guinea-Bissau was connected to both Cameroon and Mali. This is the first study that
describes the HIV-1 molecular epidemiology in a West African country by combining the results of subtype distribution with
analyses of epidemic origin and epidemiological linkage between locations. The multiple introductions of HIV-1 into
Guinea-Bissau, during a short time-period of five years, coincided with and were likely influenced by the major immigration
wave into the country that followed the end of the independence war (1963–1974).
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Introduction
Human immunodeficiency virus type 1 (HIV-1) originated in
West Central Africa via cross-species transmission from
chimpanzees around the beginning of the 20
th century, and
has since then diversified in the human population [1,2]. Today,
the most prevalent group of HIV-1 is the main (M) group which
has been divided into subtypes (A–D, F–H, J–K), sub-subtypes
(A1–A4, F1–F2) and 43 circulating recombinant forms (CRFs),
distinguished on both the genetic level and geographic location
[3].
HIV-1 mutates and recombines at extremely high rates, and the
rapid generation of genetic diversity makes it possible to study the
dynamics of evolutionary changes over time and to trace patterns
of viral dispersal in HIV-1 epidemics [4,5]. Coalescent theory in a
phylogenetic framework has proven to be a useful tool to infer
population history, and it has been used to study a variety of
pathogens, including HIV-1, in different geographic regions
[6,7,8,9].
Little is known about the HIV-1 population dynamics and
migration events that have influenced the HIV-1 epidemic in
countries in West Africa. The dominating form of HIV-1 in this
region is the CRF02_AG, a recombinant between the subtypes A
and G [10,11,12,13,14,15]. Most countries in West Africa
reported an almost exponential increase in HIV-1 prevalence
during the 1990’s, reaching a steady-state level of approximately
one to six percent by the end of the 1990’s [16]. In Guinea-
Bissau, a few cases were reported during the 1980’s, and steady-
state prevalence level of four to seven percent was reached by the
end of the 1990’s [17,18,19,20,21,22]. Since the emergence of the
AIDS epidemic, information on HIV-1 subtype distribution in
Guinea-Bissau is limited to one study. Andersson et al. studied
samples from 27 HIV-1 infected individuals collected 1994–1996
and found that 81% of the individuals were infected by
CRF02_AG, 15% with subtype A, and one individual with
subtype B [10].
The objective of the current study was to characterize the
molecular epidemiology of HIV-1 in Guinea-Bissau, West Africa.
We amplified and sequenced the HIV-1 env V1-V3 region
(,940 bp) from plasma samples of 82 individuals from Guinea-
Bissau collected between 1993 and 2008. Maximum likelihood
(ML) and Bayesian phylogenetic methods were used to reconstruct
the epidemic and the demographic history of HIV-1 in Guinea-
Bissau. By combining spatial and temporal information in a
Bayesian phylogeographic framework we reconstructed migration
events both within Guinea-Bissau and between Guinea-Bissau and
other West African countries. The results of this study may have
implications in understanding the epidemic potential of different
HIV-1 variants, particularly in West African countries, but also in
other regions of the world.
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Prevalence of HIV-1 subtypes and recombinants in
Guinea-Bissau
Phylogenetic analyses showed that the most common forms of
HIV-1 in Guinea-Bissau is the CRF02_AG (57%) and the
subsubtype A3 (20%) (Table S1). In addition, four sequences
(5%) were subtype C, one subsubtype A1 and one CRF06_cpx.
Finally, 13 (16%) of the sequences were subtype A-like and
clustered with long branch lengths within or close to the
CRF02_AG and the A3 clusters. BootScan analyses indicated
that all 13 sequences were recombinants of HIV-1 CRF02_AG
and subsubtype A3. Interestingly, 12 of the 13 recombinants had a
breakpoint within the C2 region of gp120. To confirm
recombination, we split these sequences at their respective
recombination breakpoint and constructed ML trees for each
part together with the rest of the sequences from Guinea-Bissau
and reference sequences. As expected, all of the identified
recombinants clustered partly within the CRF02_AG cluster and
partly within the subsubtype A3 cluster.
Next, we investigated differences in subtype distribution
between the capital Bissau and rural Guinea-Bissau to evaluate
the possibility of local epidemics related to subtype. No such
differences were found: HIV-1 CRF02_AG (Bissau 55%; rural
Guinea-Bissau 62%); subsubtype A3 (Bissau 23%; rural Guinea-
Bissau 12%) (p=0.35, two-tailed Fisher’s exact test). Two
noteworthy exceptions were found: (1) all four individuals infected
with HIV-1 subtype C were sampled in the capital Bissau, and (2)
there was a trend for a more profound CRF02_AG epidemic in
the north-western part (10 out of 12 (83%) of the sampled
sequences were CRF02_AG) as compared to the north-eastern
part (three out of 8 (38%) were CRF02_AG) of rural Guinea-
Bissau (p=0.06).
Timing of the introductions of HIV-1 CRF02_AG and A3 in
Guinea-Bissau
To investigate the origin of the HIV-1 CRF02_AG and
subsubtype A3 epidemics in Guinea-Bissau, we first determined
different introduction events. Two sample sets with sequences
from Guinea-Bissau were constructed; one with the CRF02_AG,
and one with subsubtype A3 sequences. Thirty-six and 46
reference sequences from Genbank were included in the
CRF02_AG and subsubtype A3 data sets, respectively. These
were determined using the basic local alignment search tool
(BLAST) (www.ncbi.nlm.hih.gov/BLAST) to select for the 10
most similar hits for each Guinea-Bissau-specific sequence. Details
of the construction of the two sample sets can be found in the
Materials and Methods section. ML and Bayesian phylogenies
were reconstructed and clusters supported with zero-branch-
length test (ZBLT) values of p,0.001 and posterior probabilities of
.95%, were considered to be highly supported (branches denoted
**, Figures 1a and b). One cluster in the CRF02_AG analysis was
supported with a ZBLT value of p=0.005 and a posterior
probability value of 93% (the branch is denoted *, Figure 1a). We
identified five well-supported Guinea-Bissau-specific clusters for
CRF02_AG and one for subsubtype A3. We also noted that
clusters three to five in the CRF02_AG phylogeny formed a cluster
together with four other sequences from Guinea-Bissau and two
sequences from Cameroon (Figure 1a), possibly reflecting a single
common introduction. However, this large cluster was supported
by neither the ZBLT nor the posterior probability. In fact, in the
Bayesian maximum clade credibility tree (MCC), these three
clusters did not form any potential monophyletic cluster.
Next, we estimated the timing of the identified introductions in
Guinea-Bissau. The first introduction of the CRF02_AG in
Guinea-Bissau was estimated to 1976 (95% highest posterior
probability (HPD) 1968–1982), followed by four additional
introductions during a short time period (1979–1981) (Table S2).
The tMRCA for all of the CRF02_AG sequences was 1969 (95%




21 (95% HPD 2.84–4.76610
23). In the
subsubtype A3 analysis, the tMRCA of the Guinea-Bissau cluster
was estimated to 1979 (95% HPD 1960–1988). In the phylogeny
of HIV-1 subsubtype A3, we identified a cluster containing both
our sequences from Guinea-Bissau and some reference sequences
(determined to be of subsubtype A3) that were separated from the
other reference sequences (determined subtype A sequences, but
not subsubtyped) (Figure 1b). Not many sequences are annotated
as subsubtype A3 sequences in Genbank or the Los Alamos
sequence data base, and we therefore interpreted this cluster as a
true subsubtype A3 cluster. Neither the tMRCA nor the
evolutionary rate for this subsubtype has been presented before.
We reanalyzed this cluster and found the tMRCA of subsubtype




21 (95% HPD 1.61–
4.93610
23) (Table S2).
Detailed demographic analysis of the Guinea-Bissau HIV-
1 epidemic
To reconstruct the demographic history in Guinea-Bissau we
focused on the two major clusters identified for the CRF02_AG
(cluster 2) and the subsubtype A3 (cluster 1) epidemics, separately.
The remaining clusters (CRF02_AG cluster 1 and 3–5) consisted
of too few sequences to be subjected for demographic analysis.
The tMRCA for cluster 2 of the CRF02_AG analysis dated back
to 1976 (95% HPD 1968–1982), and contained 17 sequences from
Guinea-Bissau. Demographic reconstruction of this cluster showed
an exponential increase in median number of effective infections
during 1985–1990 (30 to 562 effective infections), followed by an
asymptotic phase towards the present (Figure 2a). A comparative
demographic analysis of all Guinea-Bissau-specific CRF02_AG
sequences together with the reference sequences (in total 77
sequences), showed a more pronounced demographic history
(Figure 2b). An initial moderate growth phase during the 1970’s
was followed by a rapid exponential growth phase between 1981
and 1983, during which the number of effective infections
increased from an initial median value of 350 effective infections
in 1981, to a final median estimate of 4232 effective infections in
1983.
Next, we reconstructed the demographic history for subsubtype
A3, both in Guinea-Bissau (cluster 1, 15 sequences), and for
Guinea-Bissau specific sequences together with true subsubtype A3
reference sequences (in total 21 sequences). The tMRCA was
estimated to 1979 (95% HPD 1960–1988), and the demographic
analysis of subsubtype A3 in Guinea-Bissau showed a similar trend
as for the CRF02_AG epidemic, with an exponential increase in
the median number of effective infections between 1984 and 1987
(from 97 to 661) (Figure 2c). Inspection of the median estimates of
the demographic history of the entire subsubtype A3 in West
Africa suggested a slower and longer initial growth phase as
compared to the CRF02_AG, starting in 1975 (at 12 effective
infections), and ending in 1991 (at 1390 effective infections)
(Figure 2d).
To further characterize the demographic history of HIV-1 in
Guinea-Bissau, we calculated the median proportion of the current
lineages that existed during 1970–1975, 1975–1980, 1980–1985,
1985–1990, and 1990–1995. The analyses showed that 79% (95%
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HPD 31%–100%) of the subsubtype A3 lineages were present in
the country already in 1985 and 1990, respectively (Table 1).
Net migration rates for Guinea-Bissau between 1950 and
2010
Emigration from and immigration to Guinea-Bissau was
dissected by investigating data of net migration rates from the
United Nations World Population Prospects (United Nations
Population Division, 2010). Two major migration waves were seen
for Guinea-Bissau: (1) a net migration outflux of up to 13 of 1000
people during the mid 1960’s, and (2) a net migration influx of up
to 17 of 1000 people during the mid 1970’s, (Figure 3). Both of
these migration waves coincided with the beginning and the end of
the independence war (1963–1974).
Reconstruction of spatial dispersal patterns related to
Guinea-Bissau
To reconstruct the HIV-1 CRF02_AG and A3 migration
patterns over time, we removed sequences lacking information of
sampling place and sampling date from the datasets used in the
cluster analyses (67 and 21 sequences of CRF02_AG and
subsubtype A3, respectively). For the subsubtype A3 analysis,
only sequences from the identified A3 cluster were allowed. Both
datasets indicated an association between geographic location and
shared ancestry in the phylogenies: CRF02_AG: PS: p,0.01; AI:
p,0.01); subsubtype A3: PS: p=0.06; AI: p=0.02.
The phylogeographic analyses indicated that both the HIV-1
CRF02_AG and subsubtype A3 epidemics in Guinea-Bissau
originated in the capital Bissau, from where they then dispersed
out to smaller cities and villages in the countryside, probably during
the 1980’s and 1990’s (Figures 4 and 5, Videos S1 and S2).
Investigation of the diffusion patterns between Guinea-Bissau and
other West African countries showed three well-supported connec-
tions for HIV-1 CRF02_AG, while none were identified for
subsubtype A3. One migration event of HIV-1 CRF02_AG
originated in Cameroon (1977), and reached Guinea-Bissau before
2003 (the analyzed sample was collected in 2007, but inspection of
patient history data showed that the subject was HIV-1 positive in
Guinea-Bissau already in 2003) (Figure 6, Video S3, Table S1). In
addition, we found two separate migration events between Guinea-
Bissau and Mali. Both originated in Guinea-Bissau in 1975 and
1979, respectively, and reached Mali before 2003 (Video S3).
Discussion
HIV-1 subtype A and CRF02_AG represents approximately
27% of the worldwide HIV-1 infections, most of them prevailing
Figure 1. a–b. Determination of Guinea-Bissau-specific clusters
in HIV-1 CRF02_AG and subsubtype A3 phylogenies. Maximum-
likelihood trees were reconstructed based on the sequences from
Guinea-Bissau together with reference sequences (A. CRF02_AG and B.
subsubtype A3). The scale bar at the bottom of each tree represents
0.01 nucleotide substitutions per site. Asterisks along branches
represent significant monophyletic clusters (**: Zero-branch-length test
p-values ,0.001, and posterior probabilities .95% in corresponding
Bayesian analysis. *: Zero-branch-length test p-values ,0.01, and
posterior probabilities .90%). Statistically supported clusters are
numbered according to appearance in tree and the corresponding
tMRCA are marked with filled circles (red circles = Guinea-Bissau-
specific tMRCAs, and black circles = the tMRCA of the CRF02_AG or
subsubtype A3). The colours represent the country or geographic
region representing the origin of each tip in the phylogeny.
doi:10.1371/journal.pone.0017025.g001
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West Africa have shown that the CRF02_AG represents 50–70%
of the HIV-1 infections in this region. We studied 82 HIV-1
infected individuals from Guinea-Bissau, and found that 57% were
infected with CRF02_AG and 21% with subtype A. Detailed
phylogenetic analysis of subtype A sequences showed that the vast
majority of them (94%) belonged to the previously described
subsubtype A3 [24,25,26]. This subsubtype was originally
described in Senegal (with a prevalence of 16%), and has been
shown to circulate in several countries in West Africa. We also
identified 13 recombinants between HIV-1 CRF02_AG and
subsubtype A3. The recombination breakpoints were located in
the gp120 C2 region in 12 of the 13 recombinants. This region has
previously been shown to be a recombination hot spot for subtype
B [27,28]. In addition, in the study by Meloni et al., where the
subsubtype A3 was first described, two out of five putative HIV-1
A3 sequences were found to be recombinants between the
CRF02_AG and the subsubtype A3 [24]. One of these sequences
displayed a recombination breakpoint in the gp120 C2 region.
To estimate the timing of the introduction of HIV-1 in Guinea-
Bissau we focused on the two dominating forms, the CRF02_AG
and subsubtype A3. In the CRF02_AG phylogeny we identifiedone
major and four minor clusters of Guinea-Bissau-specific sequences,
indicating a scenario of multiple introductions into Guinea-Bissau
(Figure 1a). The introduction of the major CRF02_AG cluster
dated back to 1976, and was then followed by several introductions
during the late 1970’s and early 1980’s. The timing of these
introductions fits well with the results from early studies of HIV-1
seroprevalence in West Africa [22,29]. In a study by Fultz et al., one
out of 440 analyzed serum samples collected in 1980 reacted in an
HIV-1 radio-immunoprecipitation assay, and were considered to be
potentially HIV-1 positive by the authors [22]. Kanki et al. analyzed
2131 serum samples, collected 1985–1987, from Guinea-Bissau and
the neighbouring countries Senegal, Guinea and Mauritania and
found an HIV-1 seroprevalence of 0–0.7% in the analyzed samples
[29]. The results of these studies indicate an arising HIV-1 epidemic
in West Africa during the early 1980’s. The estimated dates of the
HIV-1 CRF02_AG introductions into Guinea-Bissau are also in
line with the scenario seen in the demographic analyses. The
Bayesian skyline plot (BSP) analysis suggested an initial and almost
asymptotic growth period of effective infections followed by a rapid
exponential growth phase, starting around 1985 with a median of
30 effective infections and ending in 1990 with an almost 20-fold
increase in median effective infections to 562 in Guinea-Bissau
(Figure 2a). A similar pattern was seen in the analysis of the
prevalence of current lineages over time. Only 23% of the current
Guinea-Bissau lineages existed in the country in 1980. In 1985 the
number had increased exponentially to 79%, and in 1990 almost all
Figure 2. a–d. Bayesian skyline plots for the CRF02_AG and subsubtype A3 epidemics. Non-parametric median estimates of the number
of effective infections over time for a. the CRF02_AG Guinea-Bissau cluster 2, b. the CRF02_AG epidemic in West Africa, c. the subsubtype A3 Guinea-
Bissau cluster 1, and d. the subsubtype A3 epidemic in West Africa. All plots were based on the relaxed clock assumption. The grey lines represent the
upper and lower 95% highest posterior density estimates. The pink area highlights the decade following the time period (1976–1981) of the
estimated HIV-1 introductions into Guinea-Bissau.
doi:10.1371/journal.pone.0017025.g002
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country. When examining the demographic growth patterns of all
CRF02_AG sequences in our dataset (representing 12 different
countries) we found that the most profound increase in number of
effective infections took place during 1981–1983 (with a rapid
increase in median number of effective infections from 350 to 4232)
(Figure 2b). Interestingly, this increase coincided with most of the
introductions into Guinea-Bissau and preceded the major increase
in number of effective infections in Guinea-Bissau. A closer
inspection of the BSP suggested another rapid growth phase at an
earlier time-point, between 1972 and 1974 (with an increase of four
times in number of effective infections, from 11 to 44).
In the subsubtype A3 analysis, we identified one monophyletic
cluster (1979), suggesting a major introduction followed by local
epidemic spread (Figure 1b). The demographic analysis of the
subsubtype A3 epidemic in Guinea-Bissau, showed similar
patterns as for the CRF02_AG epidemic, with an exponential
growth phase during the mid 1980’s (1984–1987) (Figure 2c).
Interestingly, this growth phase seemed to both predate, and to be
more rapid than the one seen when analyzing all of the subsubtype
A3 sequences (1985–1991) (Figure 2d).
We recognize that the demographic analyses of both the
subsubtype A3 epidemic in West Africa and the local epidemics
in Guinea-Bissau (CRF02_AG cluster 2 and subsubtype A3 cluster
1) are based on relatively few sequences (reflected by large HPD
intervals,Figures2a, c–d), and analysesoflargerdatasetsareneeded
to confirm the results presented in this study. The rationale behind
analysing well-supported clusters of country-specific sequences
(instead of analysing all country-specific sequences together,
regardless of clustering) is that it gives the highest probability of
extracting demographic patterns specific for the country under
study, without any influence of sequences from other countries.
Although we stress that the demographic estimates should be
interpreted with caution, it is interesting to note that the median
estimates of the local demographic patterns show similar trends for
both CRF02_AG and subsubtype A3 in Guinea-Bissau (Figures 2a
and c). The timing of the increase in median number of effective
infections also fits well with the more distinguished demographic
pattern seen for the entire CRF02_AG epidemic (Figure 2b).
The phylogeographic analyses showed that HIV-1 was intro-
duced into the urban centre (Bissau), and then spread throughout
the country, a scenario that is similar to what has been reported for
Cote d’Ivoire [13]. In addition, strains of the CRF02_AG epidemic,
the dominant form of HIV-1 in Guinea-Bissau, started to migrateto
rural areas almost 10 years before subsubtype A3, despite similar
introduction dates (Figures 4 and 5). This also coincided with the
exponential growth phase of the major CRF02_AG lineage
(Figure 1a, cluster 2). In contrast, the subsubtype A3 epidemic
grew exponentially in Bissau, and did not start to migrate to rural
areas until after this phase. One might speculate that the subsubtype
A3 epidemic grew in a small subpopulation not as prone to migrate
as compared to the subpopulations infected with the CRF02_AG.
Table 1. Bayesian estimates of median time to the most
recent common ancestor, and median proportions of current
lineages existing at the studied time-points.
CRF02_AG - RC-BSP* Subsubtype A3 - RC-BSP*
Median 95% HPD{ Median 95% HPD{
tMRCA{ 1976 1968–1982 1979 1960–1988
% strains in 1980 23.4 0.2–80.8 0.6 0.6–100
% strains in 1985 78.7 29.8–93.6 37.5 0.6–100
% strains in 1990 93.6 91.5–97.9 100.0 31.3–100.0
% strains in 1995 93.6 91.5–95.7 93.8 93.8–100.0
In this analysis, the posterior distribution of trees was used to examine the
median percentage of 2008 years strains (CRF02_AG and A3, separately) in
Guinea-Bissau present in the examined years. This estimate gives an indication
of changes in strain diversity during the time-periods under study.
*RC: Relaxed clock assumption. BSP10: Bayesian skyline plot used as tree prior.
{HPD: The lower and upper boundaries in 95% high posterior density interval.
{The estimated year of the most recent ancestor of CRF02_AG and subsubtype
A3 in Guinea-Bissau, respectively. tMRCA: time to most recent common
ancestor.
doi:10.1371/journal.pone.0017025.t001
Figure 3. Net migration rates over 5-year intervals. Mean number of immigrating and emigrating people per 1000 individuals over different 5-
year intervals from 1950 to 2010 for Guinea-Bissau and neighbouring countries (Guinea, Mali, Senegal, and The Gambia). The pink area highlights the
time period of the estimated HIV-1 introductions into Guinea-Bissau. Data were obtained from the United Nations World Population Prospects
(United Nations Population Division, 2010) [33].
doi:10.1371/journal.pone.0017025.g003
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than the CRF02_AG. Competition assays in peripheral blood
mononuclear cells in vitro, have shown that the CRF02_AG out-
competes both its parental strains subtype A and G, respectively
[30,31]. The migration analyses between Guinea-Bissau and other
countries in West Africa showed connections to both Cameroon
and Mali (Figure 6). Since the CRF02_AG is a recombinant
between the ‘‘pure’’ subtypes A and G, which are prevalent in
central West Africa, it is reasonable to believe that the CRF02_AG
arose in this area of Africa. Therefore it is not surprising to find a
shared common ancestor of the Guinea-Bissau CRF02_AG
epidemic in Cameroon. The connection between Guinea-Bissau
and Mali is also expected since the two countries have many
business interests in common. Although the migrations established
in this study are important in tracing disease spread connected to
Guinea-Bissau, we emphasize that these are the migrations that we
can extract from the analyzed sequences. In this analysis we used all
available CRF02_AG gp120 V1-V3 sequences with known
sampling date and geographic location. However, it is both possible
and likely that other migrations have existed in addition to those
presented here and an extended analysis of a larger amount of
sequences could give a more detailed picture of HIV-1 disease
spread inter-connected to Guinea-Bissau.
Increased mobility and rapid urbanization is a known risk factor
for acceleration of HIV transmission, creating epidemics in central
cities before spreading out to more peripheral regions [32]. The
estimated introductions of HIV-1 CRF02_AG in the end of the
1970’s coincided with an increased immigration of people to
Guinea-Bissau. According to the UN Populations Division, there
was a net immigration rate of 17 per 1000 people during the
period 1975–1980 into Guinea-Bissau, which corresponds in time
to the repatriation of Guinea-Bissauan refugees after the
declaration of independence in 1974 (Figure 3) [33]. Up to 13%
of the population had fled, mainly to Senegal and Guinea during
the war against the colonial Portuguese in 1963–1974 [34].
Another consequence of the war was a massive influx of
population to the capital Bissau, increasing its size from 18.000
inhabitants in 1950 to 110.000 in 1974 [34].
This study is the first to investigate the molecular epidemiology
and demography in a West African country, and the first to study
the HIV-1 subsubtype A3 in this context. Understanding factors
influencing differences in distribution, demographic history and
migration patterns of different HIV-1 subtypes in West African
countries are crucial to understand the epidemic potential of HIV-
1 in this part of Africa.
Materials and Methods
Ethics
The study was approved by the Research Ethics Committee at
the Karolinska Institute, Stockholm (RECKI), and the Ministries
of Health and the Interior in Guinea-Bissau (MHIGB). RECKI
Figure 4. Temporal dynamics of spatial HIV-1 CRF02_AG diffusion within Guinea-Bissau. Snapshots of the HIV-1 CRF02_AG dispersal
pattern within Guinea-Bissau. Lines between locations represent branches in the maximum clade credibility tree (MCC) along which well-supported
location transitions occurs. The diffusion process was visualized in Google Earth (http://earth.google.com).
doi:10.1371/journal.pone.0017025.g004
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participants, due to the high rate of illiteracy in the cohort.
Study population
Nucleotide sequences used in this study were selected from a
sample set of 1,562 HIV-1 env V1-V3 clones derived from 156
blood plasma samples of 82 individuals, collected between 1993
and 2008 (Table S1). Seventy-seven of the samples were selected
from a cohort of police officers, and five samples (DL11967-
DL11971) were from a case control study [17,19,35,36]. All
samples had been collected in Guinea-Bissau, West Africa, and
were selected based on sample availability, follow up time and
disease status (patients in both asymptomatic phase and in late-
stage disease are represented in the dataset). The samples used in
this study are considered to be collected from individuals
representative of the general population since they were all
healthy by inclusion, did not display any differences in high risk-
behaviour, and were all recruited from different geographical
regions of Guinea-Bissau. Sample sets used in this study are further
described in the section of Sample sets.
Amplification and sequencing
Viral RNA was extracted and purified from blood plasma
samples, using RNeasy Lipid Tissue Mini Kit (Qiagen, Stockholm,
Sweden) with minor modifications from the manufacturer’s
instructions. Briefly, 200 ml of blood plasma was disrupted in
2000 ml Qiazol and 10 mg Carrier RNA was added (Qiagen). The
aqueous phase was loaded onto a spin column by multiple loading
steps. RNA was eluted in 40 ml of RNase-free water and treated
with DNase I (Fermentas, Helsingborg, Sweden). Viral RNA was
reverse transcribed using gene-specific primers, and the V1-V3
region was amplified by a nested PCR approach (The Super-
Script
TM III One-Step RT-PCR System with PlatinumH Taq
DNA Polymerase and PlatinumH Taq DNA Polymerase High
Fidelity, Invitrogen, Copenhagen, Denmark) according to the
manufacturer’s instructions using primers JE12F and V3A_R2 for
one-step RT-PCR and E20A_F and JA169 for nested PCR
[37,38]. The amplified V1-V3 region of approximately 940 base
pairs (nucleotides 6430 to 7374 in HXB2; GenBank accession
number K03455) was cloned using the InsTAclone cloning system
(Fermentas) and TOP10 cells (Invitrogen). Twelve colonies were
routinely picked from each sample and the cloned fragments were
amplified with PlatinumH Taq DNA Polymerase High Fidelity
(Invitrogen) using conventional M13 primers (220 and 224).
Individual clones were purified and sequenced using the BigDye
Terminator v1.1 Cycle Sequencing Kit (Applied Biosystems,
Stockholm, Sweden) according to the manufacturer’s instructions
using primers E20A_F and JA169 [37].
Explorative sequence analysis
Sequences were assembled, and contigs were analyzed with
CodonCode Aligner v1.5.2 (CodonCode Corporation, Dedham,
Figure 5. Temporal dynamics of spatial HIV-1 subsubtype A3 diffusion within Guinea-Bissau. Snapshots of the HIV-1 subsubtype A3
dispersal pattern within Guinea-Bissau. Lines between locations represent branches in the maximum clade credibility tree (MCC) along which well-
supported location transitions occurs. The diffusion process was visualized in Google Earth (http://earth.google.com).
doi:10.1371/journal.pone.0017025.g005
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further analysis. A multiple alignment of all 1,562 sequences was
created in MEGA4 using the Clustal algorithm [39,40,41]. The
alignment was trimmed in the 3’ end into complete codons,
realigned at the protein level, and codon stripped to a final length
of 654 bp. An explorative neighbor-joining (NJ) tree was
constructed in MEGA4, using a maximum composite likelihood
substitution model (default settings), to verify that all clones were of
patient-specific origin (data not shown).
PHI-test and subtype determination
Sequence recombinants violate phylogenetic inference and can
lead to misinterpretations of analyzed data [42]. We used the
pairwise homoplasy index (PHI) as implemented in Splitstree
v4.10 to screen the 1,562 sequences for instances of intra-patient
recombination events as described by Salemi et al. [43,44,45]. One
hundred and eighty five potential recombinants were found and
removed to a final non-recombinant dataset of 1,377 sequences
representing 156 sample time-points of 82 HIV-1 infected
individuals. To determine the HIV-1 subtype, one clone from
each patient was randomly chosen to a sample set of 82 V1-V3
sequences and aligned with a reference sequence dataset of all
major subtypes, subsubtypes and CRFs (downloaded from Los
Alamos Sequence Database) in MEGA4, as described. An NJ tree
was constructed in MEGA4 with complete deletion of gap
positions and by using a maximum composite likelihood
substitution model with heterogeneous pattern among lineages
with a gamma distribution of 1.0. The phylogenetic reconstruction
was bootstrapped 1,000 times to separate sequences of different
subtypes. The gp120 V1-V3 region of CRF02_AG is subtype A-
derived, and separation of subclusters belonging to either
CRF02_AG or subtype A were not possible in this tree. To
further characterize these sequences we realigned our sequences
with an extended HIV-1 A-like reference sequence dataset
(including the subsubtype A3 which were not included in the
original dataset but has been reported to circulate in West Africa,
Table S3) using PRANK+F with a NJ tree (constructed in
MEGA4) as guide tree [24,46]. The PRANK+F algorithm aligns
sequences using phylogenetic information and has been shown to
align sequences in a more evolutionary sound way, and was
therefore used instead of the Clustal algorithm in this detailed
analysis [46]. The alignment was manually edited and codon-
stripped to a final sequence length of 681 nucleotides. A best-
fitting nucleotide substitution model for the dataset was estimated
using the Akaike information criterion (AIC) as implemented in
Modeltest v3.6 [47]. A maximum-likelihood (ML) phylogenetic
tree was constructed using the inferred model, GTR+I+G, with
Garli v0.951 (www.bio.utexas.edu/faculty/antisense/garli/Garli.
html) [48]. This method efficiently maximizes the tree loge
likelihood by using a genetic algorithm implementing the nearest
neighbor interchange (NNI) and the subtree pruning regrafting
(SPR) algorithms on a random starting tree to simultaneously find
and optimize the topology and branch lengths [48,49]. Support for
internal branches was obtained by the ML-based zero-branch-
length test (ZBLT) as implemented in PAUP* v4.0b10 [50]. We
also inferred Bayesian phylogenies under the selected model using
MrBayes v3.1.2 [51]. Two runs of four chains each (one cold and
three heated, temp=0.20) were run for 50 million generations,
with a burn-in of 25%. The results of the two runs were combined
in Logcombiner v1.5.3 [5]. Convergence was assessed by
calculating the effective sampling size (ESS) using Tracer v1.5
[52]. All parameter estimates showed ESS values higher than 200.
A final Bayesian majority-rule consensus tree was obtained by
TreeAnnotator v1.5.3 with a burn-in of 25%.
Recombination analysis
Five of the subtype A-like sequences fell in between the
CRF02_AG and the A3 monophyletic clusters. Scattering between
clusters or long branch lengths are characteristics typical for
recombinant sequences [27]. To further characterize the dataset
we first performed BootScan analysis to determine possible
recombination breakpoints, using Simplot v3.5. NJ trees with a
200 bp moving window along the sequence alignment in 20 bp
increments were constructed, and a transition/transversion ratio
of 1.5 was used with a F84 model of evolution [53]. Two
subgroups of A3 and CRF02_AG sequences were used as putative
parental sequences, whereas a subgroup of subtype C sequences
was used as outgroup. The consensus sequences of the subgroups
were used in the analysis and 1,000 bootstrap replicates were
generated for each analysis. Thirteen sequences from Guinea-
Bissau showed mixed clustering between HIV-1 CRF02_AG and
subsubtype A3 in the BootScan analysis, and displayed profound
recombination breakpoints. We then examined each putative
recombinant by splitting the dataset at each identified recombi-
nation breakpoint. Maximum likelihood and Bayesian trees were
reconstructed as described, and sequences that clustered partly
within the CRF02_AG cluster and partly within the subsubtype
A3 cluster were considered to be A3/CRF02_AG recombinants.
Sample sets for estimation of evolutionary rates and
dates
Two sample sets with sequences from Guinea-Bissau were
constructed; one with the CRF02_AG, and one with subsubtype
A3 sequences. Since the sequences were intended to be used for
estimation of evolutionary rates and dates we aimed at the widest
range of collection years because a long interval of sampling years
naturally provides more information about rates and divergence
times than a short interval [54]. To construct a reference sequence
dataset for each of the two datasets we used the basic local
alignment search tool (BLAST) (www.ncbi.nlm.hih.gov/BLAST)
to select for the 10 most similar hits for each Guinea-Bissau-
specific sequence. Sequences sampled from the same patients were
removed to a final reference dataset of 36 and 46 sequences for
CRF02_AG and A3, respectively. Accession numbers of the
sequences can be found in Tables S4 and S5.
Cluster identification and estimation of evolutionary
rates and dates
The two sample sets (CRF02_AG and A3) were aligned with the
corresponding reference datasets using PRANKF+, as described in
section PHI-test and subtype determination. The best fitting nucleotide
substitution model was determined using Modeltest v3.6 (AIC).
Maximum likelihood (ML) and Bayesian trees were inferred using
Garli v0.951 and MrBayes v3.1.2, respectively. Statistical support
for internal branches were determined by the ML-based zero-
Figure 6. Temporal dynamics of spatial HIV-1 CRF02_AG diffusion between Guinea-Bissau and other African countries. Snapshots of
the HIV-1 CRF02_AG dispersal pattern between Guinea-Bissau and other African countries. Lines between locations represent branches in the
maximum clade credibility tree (MCC) along which well-supported location transitions occurs. The diffusion process was visualized in Google Earth
(http://earth.google.com).
doi:10.1371/journal.pone.0017025.g006
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ML-phylogenies, and by posterior probability values for Bayesian
maximum clade credibility trees (MCC) (determined by TreeAn-
notator v1.5.3, as described).
Estimates of evolutionary rates (nucleotide substitutions site
21
year
21) and timing of the most recent common ancestors
(tMRCA) of the datasets and clusters were performed using a
Bayesian Markov Chain Monte Carlo (MCMC) approach as
implemented in BEAST v1.5.3 [5]. The time span for the HIV-1
CRF02_AG and A3 datasets were 1993–2008 and 1995–2008,
respectively. We used the SRD06 model implemented in BEAST
v1.5.3 (a HKY85 nucleotide substitution model, with four category
gamma distributed rate variation among sites, and two partitions
in codon positions (1
st+2
nd,3
rd codon)), which has been shown to
be the best performing model for analysis of most viral datasets
[55]. A relaxed clock with an uncorrelated lognormal distributed
prior was used with the Bayesian skyline plot growth model (10
grouped intervals separated by coalescence events) as demographic
model. The BSP allows the effective population size to vary
between coalescence events, and does not make any restrictive
prior assumptions on the demographic history. Explorative
analyses of other coalescent demographic models resulted in
highly similar estimates of evolutionary rates and origins (Table
S2). Two independent runs of 20–100 million generations were
run and samples of trees and parameter estimates were sampled
every 2,000–10,000 generation. Convergence was assessed in
Tracer v1.5, and the two runs were combined using Logcombiner
v1.5.3 with a burn-in of 10%. A final maximum clade credibility
tree was determined for each demographic model using TreeAn-
notator v1.5.3. Alignments, xml-files and further details about the
settings are available from the authors upon request.
Demographic analysis and estimation of proportion of
lineages
Demographic growth patterns in Guinea-Bissau were examined
by analysis of the major clusters identified for HIV-1 CRF02_AG
and A3, respectively. The demographic patterns of the entire
CRF02_AG and subsubtype A3 epidemics were estimated based
on the datasets including both sequences from Guinea-Bissau and
reference sequences. We used the Bayesian skyline plot (BSP)
population growth model with 10 grouped intervals as imple-
mented in BEAST v1.5.3 [56]. Since the BSP model allows the
effective population size to vary between coalescent events, the
model avoids making restrictive prior assumptions about the
demographic history. The MCMC analyses were run for 25–100
million generations and samples of trees and parameter estimates
were sampled every 2,500–10,000 generation. Convergence was
assessed in Tracer v1.5, and the two runs were combined using
Logcombiner v1.5.3. A final MCC tree was determined as
described.
To study the proportion of lineages existing at different time
points in the Guinea-Bissau epidemic we used the program
TreeStat v1.1 [57]. First, we aligned the CRF02_AG and A3
sequences of Guinea-Bissau, respectively, using PRANKF+ as
described. The SRD06 model with the BSP population growth
model with 10 grouped intervals was run for 20–100 million
generations with tree and parameter sampling every 2,000–10,000
generations. In this analysis, we used the posterior distribution of
trees to examine the proportion of the current CRF02_AG or A3
strains (i.e. the strains existing in Guinea-Bissau in 2008) that were
present already in the examined years (1980, 1985, 1990, 1995).
This estimate gives an indication of changes in strain diversity
during the time-periods under study.
Geographic information system data analysis
To investigate net migration rates we used data from the United
Nations World Population Prospects (United Nations Population
Division, 2010) [33]. These data are collected from various
sources, including national figures on the number of immigrants
and emigrants, estimates of net migration, estimates of interna-
tional labor migration, and refugee stock data.
Phylogeographic analysis
To study different migration events to and from Guinea-Bissau,
as well as within Guinea-Bissau we used a recently introduced
Bayesian phylogeographic model employing the Bayesian stochas-
tic search variable selection (allowing exchange rates in the
Markov model to be zero), as described by Lemey et al. [4]. In this
methodology information about both sample time-points (tempo-
ral) and geographical locations (spatial) are used together with
genetic information to infer diffusion processes among discrete
locations in timed coalescence phylogenies. This makes it possible
to test hypotheses about spatial dynamics and address phylogenetic
uncertainty in a statistically efficient fashion. Too many geo-
graphic locations in a dataset forces the diffusion process to
average over a very high state space, which can be difficult, and
may lead to uncertainties in the model (P. Lemey, personal
communication). To reduce the state space for the diffusion
process, we removed non-African sequences from the two data sets
(CRF02_AG and A3) that were used in the cluster analyses. This
resulted in one dataset for the CRF02_AG (n=68 sequences; from
six different countries (locations): Guinea-Bissau, Senegal, Mali,
Ghana, Nigeria and Cameroon), and one dataset for subsubtype
A3 (n=21 sequences; from four different countries (locations):
Guinea-Bissau, Senegal, Mali, Cameroon). To study the diffusion
process within Guinea-Bissau, Guinea-Bissau-derived sequences
were further subdivided into four different locations (Central
(Bissau), Northwest, Northeast, and South). Each phylogeographic
analysis was run for 25–100 million generations with tree and
parameter sampling every 2,500–10,000 generations in BEAST
v1.5.3. Two independent runs for each setup were assessed for
convergence in Tracer v1.5 with a burn-in of 10%, and combined
using Logcombiner v1.5. The results were summarized in an
MCC tree, and further visualized by converting the tree into a
keyhole markup language (KML) file suitable for viewing in
Google Earth (http://earth.google.com). Inferred states with node
state probabilities .80% were considered as well supported. The
KML-files were created using a java-script, as described and
distributed by Lemey et al. and only well-supported migrations are
visualized in Videos S1, S2 and S3 [4]. Alignments, xml-files and
further details about the settings are available from the authors
upon request.
To investigate the spatial admixture in our phylogeographic
analyses and statistically measure trait associations in the
phylogeny we used the parsimony score (PS) and the association
index (AI), as implemented in BaTS [58]. BaTS incorporates
statistical error arising from phylogenetic uncertainty by analysing
the posterior distribution of trees (PDT). By comparing the PDT
with a randomized null distribution, BaTS generates statistics
based on the proportion of trees from the null distribution equal
to, or more extreme than, the median posterior estimate of the
statistics from the PDT (i.e. do closely related taxa share the same
trait values to a higher extent than we would expect by chance
alone?).
Nucleotide sequence accession numbers
Nucleotide sequences were deposited in GenBank under the
following accession numbers: FJ831798, FJ831808, FJ831826,
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FJ831955, FJ831959, FJ831971, FJ831992, FJ832012, FJ832018,
FJ832041, FJ832058, FJ832064, HM745935, HM745969,
HM745992, HM746011, HM746023, HM746055, HM746065,
HM746110, HM746164, HM746180, HM746198, HM746236,
HM746256, HM746291, HM746322, HM746349, HM746370,
HM746386, HM746419, HM746448, HM746465, HM746505,
HM746532, HM746543,HM746590, HQ834865-HQ834903.
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